Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AZAD Pharma AG
Schaffhausen, Schaffhausen, Switzerlandazad.ch ↗
- Ownership
- Private
- Employees
- ~66
- Development stage
- Other
01
Overview
AZAD Pharma AG develops and supplies generic active pharmaceutical ingredients (APIs) and finished drug products using proprietary processes to circumvent patent barriers. The company specializes in value-added formulations such as preservative-free ophthalmic and oncological medicines with minimal side effects. It operates globally with offices in Switzerland, Armenia, Canada, and China.[1][2][4][5]
- Therapeutic areas
- OtherOphthalmologyOncology
- Modalities
- Small molecules (generic APIs and finished products)[1][4][5]Injectable and ophthalmic dosage forms[5]
- Industry
- Biotech
02
Partnerships
Works with European, Chinese, Indian companies for development/manufacturing partnerships.[5] No major pharma partnerships specifically named.
Beyond the preview
Go deeper on AZAD Pharma AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AZAD Pharma AG.